FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Stem Cells Transl Med / Peripheral Blood-Derived Mesenchymal Stromal Cells Promote A...
Stem cells translational medicine2014; 3(12); 1514-1525; doi: 10.5966/sctm.2014-0138

Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model.

Abstract: Mesenchymal stromal cells (MSCs) have received much attention as a potential treatment of ischemic diseases, including ischemic tissue injury and cardiac failure. The beneficial effects of MSCs are thought to be mediated by their ability to provide proangiogenic factors, creating a favorable microenvironment that results in neovascularization and tissue regeneration. To study this in more detail and to explore the potential of the horse as a valuable translational model, the objectives of the present study were to examine the presence of angiogenic stimulating factors in the conditioned medium (CM) of peripheral blood-derived equine mesenchymal stromal cells (PB-MSCs) and to study their in vitro effect on angiogenesis-related endothelial cell (EC) behavior, including proliferation and vessel formation. Our salient findings were that CM from PB-MSCs contained significant levels of several proangiogenic factors. Furthermore, we found that CM could induce angiogenesis in equine vascular ECs and confirmed that endothelin-1, insulin growth factor binding protein 2, interleukin-8, and platelet-derived growth factor-AA, but not urokinase-type plasminogen activator, were responsible for this enhanced EC network formation by increasing the expression level of vascular endothelial growth factor-A, an important angiogenesis stimulator.
©AlphaMed Press.
Get Full Text
Publication Date: 2014-10-13 PubMed ID: 25313202PubMed Central: PMC4250216DOI: 10.5966/sctm.2014-0138Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on how mesenchymal stromal cells (MSCs) from horse (equine) peripheral blood can stimulate angiogenesis – the formation of new blood vessels, by promoting the secretion of a growth factor in affected tissues. This could help in treating ischemic diseases, a condition causing restricted blood flow to tissues.

Objective of the Study

  • The primary objective of the research was to examine the presence and role of angiogenic stimulating factors in the conditioned medium (CM) of peripheral blood-derived equine mesenchymal stromal cells (PB-MSCs).
  • Another goal of the study was to understand the impact of these factors on the behaviors of endothelial cells (cells lining the blood vessels) related to angiogenesis such as proliferation and formation of new vessels.

Major Findings of the Study

  • This research found that the conditioned medium from the PB-MSCs contained significant levels of several proangiogenic factors, which are substances that stimulate the formation of blood vessels.
  • The investigators discovered that conditioned medium could induce angiogenesis in equine vascular endothelial cells. The growth factors responsible for this enhanced blood vessel network were endothelin-1, insulin growth factor binding protein 2, interleukin-8, and platelet-derived growth factor-AA.
  • The research also confirmed that a significant angiogenesis stimulator, vascular endothelial growth factor-A, increased expression levels due to the above growth factors, but not as a result of the presence of urokinase-type plasminogen activator.

Implications of the Research

  • The findings of the research offer valuable insights into how the body can naturally repair and regenerate tissues through blood vessel formation, increasing the potential for new treatments for ischemic diseases and tissue injury.
  • The study also supports the potential of using horse models in translational research – translating scientific findings into practical applications for treating such diseases.

Cite This Article

APA
Bussche L, Van de Walle GR. (2014). Peripheral Blood-Derived Mesenchymal Stromal Cells Promote Angiogenesis via Paracrine Stimulation of Vascular Endothelial Growth Factor Secretion in the Equine Model. Stem Cells Transl Med, 3(12), 1514-1525. https://doi.org/10.5966/sctm.2014-0138

Publication

Stem cells translational medicine
ISSN: 2157-6564
NlmUniqueID: 101578022
Country: England
Language: English
Volume: 3
Issue: 12
Pages: 1514-1525

Researcher Affiliations

Bussche, Leen
  • Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Van de Walle, Gerlinde R
  • Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA grv23@cornell.edu.

MeSH Terms

  • Animals
  • Culture Media, Conditioned / pharmacology
  • Endothelial Cells / cytology
  • Endothelial Cells / metabolism
  • Horses
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • Neovascularization, Physiologic
  • Paracrine Communication
  • Vascular Endothelial Growth Factor A / metabolism

References

This article includes 55 references
  1. Carmeliet P. Angiogenesis in health and disease.. Nat Med 2003 Jun;9(6):653-60.
    pubmed: 12778163doi: 10.1038/nm0603-653google scholar: lookup
  2. Yoo SY, Kwon SM. Angiogenesis and its therapeutic opportunities.. Mediators Inflamm 2013;2013:127170.
    pmc: PMC3745966pubmed: 23983401doi: 10.1155/2013/127170google scholar: lookup
  3. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis.. Cell 2011 Sep 16;146(6):873-87.
    pubmed: 21925313doi: 10.1016/j.cell.2011.08.039google scholar: lookup
  4. Sunkomat JN, Gaballa MA. Stem cell therapy in ischemic heart disease.. Cardiovasc Drug Rev 2003 Winter;21(4):327-42.
    pubmed: 14647535doi: 10.1111/j.1527-3466.2003.tb00125.xgoogle scholar: lookup
  5. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery.. Neurology 2002 Aug 27;59(4):514-23.
    pubmed: 12196642doi: 10.1212/wnl.59.4.514google scholar: lookup
  6. Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M, Gao Q, Shen LH, Zhang J, Lu M, Chopp M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells.. Glia 2005 Feb;49(3):407-17.
    pubmed: 15540231doi: 10.1002/glia.20126google scholar: lookup
  7. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector.. J Am Coll Cardiol 2005 Oct 4;46(7):1339-50.
    pubmed: 16198853doi: 10.1016/j.jacc.2005.05.079google scholar: lookup
  8. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.. Am J Physiol Renal Physiol 2005 Jul;289(1):F31-42.
    pubmed: 15713913doi: 10.1152/ajprenal.00007.2005google scholar: lookup
  9. Zhu XY, Lerman A, Lerman LO. Concise review: mesenchymal stem cell treatment for ischemic kidney disease.. Stem Cells 2013 Sep;31(9):1731-6.
    pmc: PMC3795813pubmed: 23766020doi: 10.1002/stem.1449google scholar: lookup
  10. Liew A, O'Brien T. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia.. Stem Cell Res Ther 2012 Jul 30;3(4):28.
    pmc: PMC3580466pubmed: 22846185doi: 10.1186/scrt119google scholar: lookup
  11. Altaner C, Altanerova V, Cihova M, Hunakova L, Kaiserova K, Klepanec A, Vulev I, Madaric J. Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells.. PLoS One 2013;8(9):e73722.
    pmc: PMC3771988pubmed: 24069226doi: 10.1371/journal.pone.0073722google scholar: lookup
  12. Bura A, Planat-Benard V, Bourin P, Silvestre JS, Gross F, Grolleau JL, Saint-Lebese B, Peyrafitte JA, Fleury S, Gadelorge M, Taurand M, Dupuis-Coronas S, Leobon B, Casteilla L. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.. Cytotherapy 2014 Feb;16(2):245-57.
    pubmed: 24438903doi: 10.1016/j.jcyt.2013.11.011google scholar: lookup
  13. Das AK, Bin Abdullah BJ, Dhillon SS, Vijanari A, Anoop CH, Gupta PK. Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study.. World J Surg 2013 Apr;37(4):915-22.
    pubmed: 23307180doi: 10.1007/s00268-012-1892-6google scholar: lookup
  14. Kaneko E, Izumimoto N, Toyoshima K, Abe Y, Shimokado K. [Therapeutic angiogenesis for critical limb ischemia].. Nihon Ronen Igakkai Zasshi 2013;50(3):366-8.
    pubmed: 23979343doi: 10.3143/geriatrics.50.366google scholar: lookup
  15. Zhi K, Gao Z, Bai J, Wu Y, Zhou S, Li M, Qu L. Application of adipose-derived stem cells in critical limb ischemia.. Front Biosci (Landmark Ed) 2014 Jan 1;19(5):768-76.
    pubmed: 24389220doi: 10.2741/4243google scholar: lookup
  16. Lee EJ, Park HW, Jeon HJ, Kim HS, Chang MS. Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia.. Regen Med 2013 May;8(3):283-93.
    pubmed: 23627823doi: 10.2217/rme.13.17google scholar: lookup
  17. Chen CP, Lee YJ, Chiu ST, Shyu WC, Lee MY, Huang SP, Li H. The application of stem cells in the treatment of ischemic diseases.. Histol Histopathol 2006 Nov;21(11):1209-16.
    pubmed: 16874664doi: 10.14670/hh-21.1209google scholar: lookup
  18. Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.. Cell Stem Cell 2012 Mar 2;10(3):244-58.
    pmc: PMC3294273pubmed: 22385653doi: 10.1016/j.stem.2012.02.005google scholar: lookup
  19. De Schauwer C, Van de Walle GR, Van Soom A, Meyer E. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?. Vet Q 2013 Dec;33(4):234-41.
    pubmed: 23697553doi: 10.1080/01652176.2013.800250google scholar: lookup
  20. Gershwin LJ. Veterinary autoimmunity: autoimmune diseases in domestic animals.. Ann N Y Acad Sci 2007 Aug;1109:109-16.
    pubmed: 17785296doi: 10.1196/annals.1398.013google scholar: lookup
  21. Bähr A, Wolf E. Domestic animal models for biomedical research.. Reprod Domest Anim 2012 Aug;47 Suppl 4:59-71.
    pubmed: 22827351doi: 10.1111/j.1439-0531.2012.02056.xgoogle scholar: lookup
  22. Fureix C, Jego P, Henry S, Lansade L, Hausberger M. Towards an ethological animal model of depression? A study on horses.. PLoS One 2012;7(6):e39280.
    pmc: PMC3386251pubmed: 22761752doi: 10.1371/journal.pone.0039280google scholar: lookup
  23. Gregory MH, Capito N, Kuroki K, Stoker AM, Cook JL, Sherman SL. A review of translational animal models for knee osteoarthritis.. Arthritis 2012;2012:764621.
    pmc: PMC3541554pubmed: 23326663doi: 10.1155/2012/764621google scholar: lookup
  24. Spaas JH, Guest DJ, Van de Walle GR. Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?. Sports Med 2012 Oct 1;42(10):871-90.
    pubmed: 22963225doi: 10.1007/bf03262300google scholar: lookup
  25. Spaas JH, De Schauwer C, Cornillie P, Meyer E, Van Soom A, Van de Walle GR. Culture and characterisation of equine peripheral blood mesenchymal stromal cells.. Vet J 2013 Jan;195(1):107-13.
    pubmed: 22717781doi: 10.1016/j.tvjl.2012.05.006google scholar: lookup
  26. De Schauwer C, van de Walle GR, Piepers S, Hoogewijs MK, Govaere JL, Meyer E, van Soom A. Successful isolation of equine mesenchymal stromal cells from cryopreserved umbilical cord blood-derived mononuclear cell fractions.. Equine Vet J 2013 Jul;45(4):518-22.
    pubmed: 23206252doi: 10.1111/evj.12003google scholar: lookup
  27. De Schauwer C, Goossens K, Piepers S, Hoogewijs MK, Govaere JL, Smits K, Meyer E, Van Soom A, Van de Walle GR. Characterization and profiling of immunomodulatory genes of equine mesenchymal stromal cells from non-invasive sources.. Stem Cell Res Ther 2014 Jan 13;5(1):6.
    pmc: PMC4055120pubmed: 24418262doi: 10.1186/scrt395google scholar: lookup
  28. Van de Walle GR, Peters ST, VanderVen BC, O'Callaghan DJ, Osterrieder N. Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.. J Virol 2008 Dec;82(23):11859-68.
    pmc: PMC2583640pubmed: 18815313doi: 10.1128/jvi.00868-08google scholar: lookup
  29. Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro.. Stem Cell Res Ther 2014 Jan 24;5(1):13.
    pmc: PMC4055004pubmed: 24461709doi: 10.1186/scrt402google scholar: lookup
  30. Bara JJ, McCarthy HE, Humphrey E, Johnson WE, Roberts S. Bone marrow-derived mesenchymal stem cells become antiangiogenic when chondrogenically or osteogenically differentiated: implications for bone and cartilage tissue engineering.. Tissue Eng Part A 2014 Jan;20(1-2):147-59.
    pubmed: 23895198doi: 10.1089/ten.tea.2013.0196google scholar: lookup
  31. Yew TL, Hung YT, Li HY, Chen HW, Chen LL, Tsai KS, Chiou SH, Chao KC, Huang TF, Chen HL, Hung SC. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation.. Cell Transplant 2011;20(5):693-706.
    pubmed: 21176394doi: 10.3727/096368910x550198google scholar: lookup
  32. Liu Y, Han ZP, Zhang SS, Jing YY, Bu XX, Wang CY, Sun K, Jiang GC, Zhao X, Li R, Gao L, Zhao QD, Wu MC, Wei LX. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer.. J Biol Chem 2011 Jul 15;286(28):25007-15.
    pmc: PMC3137074pubmed: 21592963doi: 10.1074/jbc.m110.213108google scholar: lookup
  33. Smith AN, Muffley LA, Bell AN, Numhom S, Hocking AM. Unsaturated fatty acids induce mesenchymal stem cells to increase secretion of angiogenic mediators.. J Cell Physiol 2012 Sep;227(9):3225-33.
    pmc: PMC3305849pubmed: 22105830doi: 10.1002/jcp.24013google scholar: lookup
  34. Yu X, Lu C, Liu H, Rao S, Cai J, Liu S, Kriegel AJ, Greene AS, Liang M, Ding X. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.. PLoS One 2013;8(5):e62703.
    pmc: PMC3650042pubmed: 23671625doi: 10.1371/journal.pone.0062703google scholar: lookup
  35. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis.. Pharmacol Rev 2004 Dec;56(4):549-80.
    pubmed: 15602010doi: 10.1124/pr.56.4.3google scholar: lookup
  36. Spinella F, Rosanò L, Di Castro V, Natali PG, Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells.. J Biol Chem 2002 Aug 2;277(31):27850-5.
    pubmed: 12023962doi: 10.1074/jbc.m202421200google scholar: lookup
  37. Shikada Y, Yonemitsu Y, Koga T, Onimaru M, Nakano T, Okano S, Sata S, Nakagawa K, Yoshino I, Maehara Y, Sueishi K. Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas.. Cancer Res 2005 Aug 15;65(16):7241-8.
    pubmed: 16103075doi: 10.1158/0008-5472.can-04-4171google scholar: lookup
  38. Martin D, Galisteo R, Gutkind JS. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex.. J Biol Chem 2009 Mar 6;284(10):6038-42.
    pmc: PMC2649103pubmed: 19112107doi: 10.1074/jbc.c800207200google scholar: lookup
  39. Azar WJ, Azar SH, Higgins S, Hu JF, Hoffman AR, Newgreen DF, Werther GA, Russo VC. IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells.. Endocrinology 2011 Sep;152(9):3332-42.
    pubmed: 21750048doi: 10.1210/en.2011-1121google scholar: lookup
  40. Das SK, Bhutia SK, Azab B, Kegelman TP, Peachy L, Santhekadur PK, Dasgupta S, Dash R, Dent P, Grant S, Emdad L, Pellecchia M, Sarkar D, Fisher PB. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.. Cancer Res 2013 Jan 15;73(2):844-54.
    pmc: PMC3548987pubmed: 23233738doi: 10.1158/0008-5472.can-12-1681google scholar: lookup
  41. Katare R, Riu F, Rowlinson J, Lewis A, Holden R, Meloni M, Reni C, Wallrapp C, Emanueli C, Madeddu P. Perivascular delivery of encapsulated mesenchymal stem cells improves postischemic angiogenesis via paracrine activation of VEGF-A.. Arterioscler Thromb Vasc Biol 2013 Aug;33(8):1872-80.
    pubmed: 23766261doi: 10.1161/atvbaha.113.301217google scholar: lookup
  42. Wang CY, Yang HB, Hsu HS, Chen LL, Tsai CC, Tsai KS, Yew TL, Kao YH, Hung SC. Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats.. J Tissue Eng Regen Med 2012 Jul;6(7):559-69.
    pubmed: 21916015doi: 10.1002/term.461google scholar: lookup
  43. Bhang SH, Lee S, Shin JY, Lee TJ, Jang HK, Kim BS. Efficacious and clinically relevant conditioned medium of human adipose-derived stem cells for therapeutic angiogenesis.. Mol Ther 2014 Apr;22(4):862-72.
    pmc: PMC3982496pubmed: 24413377doi: 10.1038/mt.2013.301google scholar: lookup
  44. Boomsma RA, Geenen DL. Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis.. PLoS One 2012;7(4):e35685.
    pmc: PMC3338452pubmed: 22558198doi: 10.1371/journal.pone.0035685google scholar: lookup
  45. Kamal A, Iskandriati D, Dilogo I. Comparison of cultured mesenchymal stem cells derived from bone marrow or peripheral blood of rats.. J Exp Integr Med 2014;4:17–22.
  46. Chong PP, Selvaratnam L, Abbas AA, Kamarul T. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells.. J Orthop Res 2012 Apr;30(4):634-42.
    pubmed: 21922534doi: 10.1002/jor.21556google scholar: lookup
  47. Watt SM, Gullo F, van der Garde M, Markeson D, Camicia R, Khoo CP, Zwaginga JJ. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential.. Br Med Bull 2013;108(1):25-53.
    pmc: PMC3842875pubmed: 24152971doi: 10.1093/bmb/ldt031google scholar: lookup
  48. Windmolders S, De Boeck A, Koninckx R, Daniëls A, De Wever O, Bracke M, Hendrikx M, Hensen K, Rummens JL. Mesenchymal stem cell secreted platelet derived growth factor exerts a pro-migratory effect on resident Cardiac Atrial appendage Stem Cells.. J Mol Cell Cardiol 2014 Jan;66:177-88.
    pubmed: 24326234doi: 10.1016/j.yjmcc.2013.11.016google scholar: lookup
  49. Salama M, Andrukhova O, Jaksch P, Taghavi S, Kelpetko W, Dekan G, Aharinejad S. Endothelin-1 governs proliferation and migration of bronchoalveolar lavage-derived lung mesenchymal stem cells in bronchiolitis obliterans syndrome.. Transplantation 2011 Jul 27;92(2):155-62.
    pubmed: 21701423doi: 10.1097/tp.0b013e318222c9eagoogle scholar: lookup
  50. Salani D, Taraboletti G, Rosanò L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.. Am J Pathol 2000 Nov;157(5):1703-11.
    pmc: PMC1885730pubmed: 11073829doi: 10.1016/s0002-9440(10)64807-9google scholar: lookup
  51. Huang SP, Wu MS, Shun CT, Wang HP, Lin MT, Kuo ML, Lin JT. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.. J Biomed Sci 2004 Jul-Aug;11(4):517-27.
    pubmed: 15153787doi: 10.1007/bf02256101google scholar: lookup
  52. Wu MH, Huang CY, Lin JA, Wang SW, Peng CY, Cheng HC, Tang CH. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.. Oncogene 2014 Mar 27;33(13):1725-35.
    pubmed: 23584483doi: 10.1038/onc.2013.109google scholar: lookup
  53. Hou Y, Ryu CH, Jun JA, Kim SM, Jeong CH, Jeun SS. IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor.. Cell Biol Int 2014 Sep;38(9):1050-9.
    pubmed: 24797366doi: 10.1002/cbin.10294google scholar: lookup
  54. Müller K, Ellenberger C, Schoon HA. Histomorphological and immunohistochemical study of angiogenesis and angiogenic factors in the ovary of the mare.. Res Vet Sci 2009 Dec;87(3):421-31.
    pubmed: 19447455doi: 10.1016/j.rvsc.2009.04.011google scholar: lookup
  55. Müller K, Ellenberger C, Hoppen HO, Schoon HA. Immunohistochemical study of angiogenesis and angiogenic factors in equine granulosa cell tumours.. Res Vet Sci 2012 Jun;92(3):471-7.
    pubmed: 21492887doi: 10.1016/j.rvsc.2011.02.016google scholar: lookup

Citations

This article has been cited 36 times.
  1. Leal Reis I, Lopes B, Sousa P, Sousa AC, Branquinho M, Caseiro AR, Pedrosa SS, Rêma A, Oliveira C, Porto B, Atayde L, Amorim I, Alvites R, Santos JM, Maurício AC. Allogenic Synovia-Derived Mesenchymal Stem Cells for Treatment of Equine Tendinopathies and Desmopathies-Proof of Concept.. Animals (Basel) 2023 Apr 11;13(8).
    doi: 10.3390/ani13081312pubmed: 37106875google scholar: lookup
  2. Kowalówka AR, Wojakowski W, Bachowski R, Deja MA. Stem cells mobilization by cardiopulmonary bypass after coronary artery bypass grafting.. Postepy Kardiol Interwencyjnej 2022 Dec;18(4):450-458.
    doi: 10.5114/aic.2022.122874pubmed: 36967861google scholar: lookup
  3. Thai VL, Candelas DO, Leach JK. Tuning the Microenvironment to Create Functionally Distinct Mesenchymal Stromal Cell Spheroids.. Ann Biomed Eng 2023 Jul;51(7):1558-1573.
    doi: 10.1007/s10439-023-03162-9pubmed: 36809393google scholar: lookup
  4. Shaik R, Xu J, Wang Y, Hong Y, Zhang G. Fibrin-Enriched Cardiac Extracellular Matrix Hydrogel Promotes In Vitro Angiogenesis.. ACS Biomater Sci Eng 2023 Feb 13;9(2):877-888.
    doi: 10.1021/acsbiomaterials.2c01148pubmed: 36630688google scholar: lookup
  5. Harman RM, Churchill KA, Parmar S, Van de Walle GR. Mesenchymal stromal cells isolated from chicken peripheral blood secrete bioactive factors with antimicrobial and regenerative properties.. Front Vet Sci 2022;9:949836.
    doi: 10.3389/fvets.2022.949836pubmed: 36090169google scholar: lookup
  6. Peng A, Lu F, Xing J, Dou Y, Yao Y, Li J, Li J, Hou R, Zhang K, Yin G. Psoriatic Dermal-Derived Mesenchymal Stem Cells Induced C3 Expression in Keratinocytes.. Clin Cosmet Investig Dermatol 2022;15:1489-1497.
    doi: 10.2147/CCID.S363737pubmed: 35941858google scholar: lookup
  7. Mabotuwana NS, Rech L, Lim J, Hardy SA, Murtha LA, Rainer PP, Boyle AJ. Paracrine Factors Released by Stem Cells of Mesenchymal Origin and their Effects in Cardiovascular Disease: A Systematic Review of Pre-clinical Studies.. Stem Cell Rev Rep 2022 Dec;18(8):2606-2628.
    doi: 10.1007/s12015-022-10429-6pubmed: 35896860google scholar: lookup
  8. Cequier A, Romero A, Vázquez FJ, Vitoria A, Bernad E, Fuente S, Zaragoza P, Rodellar C, Barrachina L. Equine Mesenchymal Stem Cells Influence the Proliferative Response of Lymphocytes: Effect of Inflammation, Differentiation and MHC-Compatibility.. Animals (Basel) 2022 Apr 11;12(8).
    doi: 10.3390/ani12080984pubmed: 35454231google scholar: lookup
  9. Shafiee S, Shariatzadeh S, Zafari A, Majd A, Niknejad H. Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering.. Front Bioeng Biotechnol 2021;9:745314.
    doi: 10.3389/fbioe.2021.745314pubmed: 34900955google scholar: lookup
  10. Vašíček J, Baláži A, Tirpáková M, Svoradová A, Ondruška Ľ, Parkányi V, Chrenek P. Secretome Analysis of Rabbit and Human Mesenchymal Stem and Endothelial Progenitor Cells: A Comparative Study.. Int J Mol Sci 2021 Nov 13;22(22).
    doi: 10.3390/ijms222212283pubmed: 34830165google scholar: lookup
  11. Lin H, Chen H, Zhao X, Chen Z, Zhang P, Tian Y, Wang Y, Ding T, Wang L, Shen Y. Advances in mesenchymal stem cell conditioned medium-mediated periodontal tissue regeneration.. J Transl Med 2021 Nov 4;19(1):456.
    doi: 10.1186/s12967-021-03125-5pubmed: 34736500google scholar: lookup
  12. Marx C, Gardner S, Harman RM, Wagner B, Van de Walle GR. Mesenchymal stromal cell-secreted CCL2 promotes antibacterial defense mechanisms through increased antimicrobial peptide expression in keratinocytes.. Stem Cells Transl Med 2021 Dec;10(12):1666-1679.
    doi: 10.1002/sctm.21-0058pubmed: 34528765google scholar: lookup
  13. Azam M, Ghufran H, Butt H, Mehmood A, Ashfaq R, Ilyas AM, Ahmad MR, Riazuddin S. Curcumin preconditioning enhances the efficacy of adipose-derived mesenchymal stem cells to accelerate healing of burn wounds.. Burns Trauma 2021;9:tkab021.
    doi: 10.1093/burnst/tkab021pubmed: 34514007google scholar: lookup
  14. Dellaquila A, Le Bao C, Letourneur D, Simon-Yarza T. In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.. Adv Sci (Weinh) 2021 Oct;8(19):e2100798.
    doi: 10.1002/advs.202100798pubmed: 34351702google scholar: lookup
  15. Yang G, Mahadik B, Choi JY, Fisher JP. Vascularization in tissue engineering: fundamentals and state-of-art.. Prog Biomed Eng (Bristol) 2020 Jan;2(1).
    doi: 10.1088/2516-1091/ab5637pubmed: 34308105google scholar: lookup
  16. Zhang YQ, Hong L, Jiang YF, Hu SD, Zhang NN, Xu LB, Li HX, Xu GD, Zhou YF, Sun KY. hAECs and their exosomes improve cardiac function after acute myocardial infarction in rats.. Aging (Albany NY) 2021 May 24;13(11):15032-15043.
    doi: 10.18632/aging.203066pubmed: 34031267google scholar: lookup
  17. Harman RM, Marx C, Van de Walle GR. Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy.. Front Cell Dev Biol 2021;9:654885.
    doi: 10.3389/fcell.2021.654885pubmed: 33869217google scholar: lookup
  18. Zhu D, Cheng K. Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out?. Cells 2021 Mar 13;10(3).
    doi: 10.3390/cells10030641pubmed: 33805763google scholar: lookup
  19. Harman RM, Patel RS, Fan JC, Park JE, Rosenberg BR, Van de Walle GR. Single-cell RNA sequencing of equine mesenchymal stromal cells from primary donor-matched tissue sources reveals functional heterogeneity in immune modulation and cell motility.. Stem Cell Res Ther 2020 Dec 4;11(1):524.
    doi: 10.1186/s13287-020-02043-5pubmed: 33276815google scholar: lookup
  20. Yang R, Gao H, Chen L, Fang N, Chen H, Song G, Yu L, Zhang Q, Zhang T. Effect of peripheral blood-derived mesenchymal stem cells on macrophage polarization and Th17/Treg balance in vitro.. Regen Ther 2020 Jun;14:275-283.
    doi: 10.1016/j.reth.2020.03.008pubmed: 32455158google scholar: lookup
  21. Marx C, Gardner S, Harman RM, Van de Walle GR. The mesenchymal stromal cell secretome impairs methicillin-resistant Staphylococcus aureus biofilms via cysteine protease activity in the equine model.. Stem Cells Transl Med 2020 Jul;9(7):746-757.
    doi: 10.1002/sctm.19-0333pubmed: 32216094google scholar: lookup
  22. Al Naem M, Bourebaba L, Kucharczyk K, Röcken M, Marycz K. Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.. Stem Cell Rev Rep 2020 Apr;16(2):301-322.
    doi: 10.1007/s12015-019-09932-0pubmed: 31797146google scholar: lookup
  23. Abdelrazik H, Giordano E, Barbanti Brodano G, Griffoni C, De Falco E, Pelagalli A. Substantial Overview on Mesenchymal Stem Cell Biological and Physical Properties as an Opportunity in Translational Medicine.. Int J Mol Sci 2019 Oct 29;20(21).
    doi: 10.3390/ijms20215386pubmed: 31671788google scholar: lookup
  24. Beugels J, Molin DGM, Ophelders DRMG, Rutten T, Kessels L, Kloosterboer N, Grzymala AAP, Kramer BWW, van der Hulst RRWJ, Wolfs TGAM. Electrical stimulation promotes the angiogenic potential of adipose-derived stem cells.. Sci Rep 2019 Aug 19;9(1):12076.
    doi: 10.1038/s41598-019-48369-wpubmed: 31427631google scholar: lookup
  25. Kamel M, Pavulraj S, Osterrieder K, Azab W. EHV-1 Pathogenesis: Current in vitro Models and Future Perspectives.. Front Vet Sci 2019;6:251.
    doi: 10.3389/fvets.2019.00251pubmed: 31417917google scholar: lookup
  26. Cortés-Araya Y, Amilon K, Rink BE, Black G, Lisowski Z, Donadeu FX, Esteves CL. Comparison of Antibacterial and Immunological Properties of Mesenchymal Stem/Stromal Cells from Equine Bone Marrow, Endometrium, and Adipose Tissue.. Stem Cells Dev 2018 Nov 1;27(21):1518-1525.
    doi: 10.1089/scd.2017.0241pubmed: 30044182google scholar: lookup
  27. Zlabinger K, Lukovic D, Hemetsberger R, Gugerell A, Winkler J, Mandic L, Traxler D, Spannbauer A, Wolbank S, Zanoni G, Kaun C, Posa A, Gyenes A, Petrasi Z, Petnehazy Ö, Repa I, Hofer-Warbinek R, de Martin R, Gruber F, Charwat S, Huber K, Pavo N, Pavo IJ, Nyolczas N, Kraitchman DL, Gyöngyösi M. Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery.. Front Bioeng Biotechnol 2018;6:35.
    doi: 10.3389/fbioe.2018.00035pubmed: 29670878google scholar: lookup
  28. Barboni B, Russo V, Berardinelli P, Mauro A, Valbonetti L, Sanyal H, Canciello A, Greco L, Muttini A, Gatta V, Stuppia L, Mattioli M. Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance.. Cell Transplant 2018 Jan;27(1):93-116.
    doi: 10.1177/0963689717724797pubmed: 29562773google scholar: lookup
  29. Harman RM, Yang S, He MK, Van de Walle GR. Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds.. Stem Cell Res Ther 2017 Jul 4;8(1):157.
    doi: 10.1186/s13287-017-0610-6pubmed: 28676123google scholar: lookup
  30. Gong M, Yu B, Wang J, Wang Y, Liu M, Paul C, Millard RW, Xiao DS, Ashraf M, Xu M. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis.. Oncotarget 2017 Jul 11;8(28):45200-45212.
    doi: 10.18632/oncotarget.16778pubmed: 28423355google scholar: lookup
  31. Esteves CL, Sheldrake TA, Mesquita SP, Pesántez JJ, Menghini T, Dawson L, Péault B, Donadeu FX. Isolation and characterization of equine native MSC populations.. Stem Cell Res Ther 2017 Apr 18;8(1):80.
    doi: 10.1186/s13287-017-0525-2pubmed: 28420427google scholar: lookup
  32. Bussche L, Rauner G, Antonyak M, Syracuse B, McDowell M, Brown AMC, Cerione RA, Van de Walle GR. Microvesicle-mediated Wnt/β-Catenin Signaling Promotes Interspecies Mammary Stem/Progenitor Cell Growth.. J Biol Chem 2016 Nov 18;291(47):24390-24405.
    doi: 10.1074/jbc.M116.726117pubmed: 27733685google scholar: lookup
  33. Markoski MM. Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical Practice.. Scientifica (Cairo) 2016;2016:4516920.
    doi: 10.1155/2016/4516920pubmed: 27379197google scholar: lookup
  34. Chouillard E, Chahine E, Allaire E, Filaire-Legendre A, Van Nhieu JT, Martinod E. Small bowel in vivo bioengineering using an aortic matrix in a porcine model.. Surg Endosc 2016 Nov;30(11):4742-4749.
    doi: 10.1007/s00464-016-4815-zpubmed: 26902616google scholar: lookup
  35. Tao H, Han Z, Han ZC, Li Z. Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications.. Stem Cells Int 2016;2016:1314709.
    doi: 10.1155/2016/1314709pubmed: 26880933google scholar: lookup
  36. Bussche L, Harman RM, Syracuse BA, Plante EL, Lu YC, Curtis TM, Ma M, Van de Walle GR. Microencapsulated equine mesenchymal stromal cells promote cutaneous wound healing in vitro.. Stem Cell Res Ther 2015 Apr 11;6(1):66.
    doi: 10.1186/s13287-015-0037-xpubmed: 25889766google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.